BioXcel CLO Sees Lower Comp After Prior Stock Options Haul
The top attorney of Connecticut-based BioXcel Therapeutics Inc. saw his compensation decrease nearly $800,000 last fiscal year, led by a reduction of more than $1.1 million in his stock option awards....To view the full article, register now.
Already a subscriber? Click here to view full article